GlassScriptPhysician profile
Syed M Iqbal
NPI 1235193087
$2,772.38
in general payments reported to CMS, 2019-2025
24 companies · $61.70 in 2025
The $61.70 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $536 · 2020: $347 · 2021: $397 · 2022: $386 · 2023: $540 · 2024: $505 · 2025: $61.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,106.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $428.11 | 2019-2024 | Farxiga, Wainua |
| Janssen Pharmaceuticals, INC | $420.18 | 2019-2022 | |
| Biotronik INC. | $307.88 | 2019-2022 | |
| Pfizer INC. | $204.17 | 2019-2024 | |
| Amarin Pharma, INC. | $187.00 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $127.53 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $120.00 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.01 | 2019-2025 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $113.51 | 2023-2024 | Inpefa |
| Merck Sharp & Dohme LLC | $90.74 | 2021-2022 | |
| Amgen INC. | $77.04 | 2019-2024 | Repatha |
| Edwards Lifesciences Corporation | $73.56 | 2020-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novo Nordisk INC | $73.05 | 2023 | Ozempic, Rybelsus |
| Scpharmaceuticals INC. | $68.55 | 2023-2025 | |
| Boston Scientific Corporation | $56.76 | 2023-2024 | Watchman Access System, Watchman Flx |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $53.23 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Sanofi-Aventis U.S. LLC | $51.07 | 2019-2023 | |
| Esperion Therapeutics, INC. | $47.17 | 2020-2021 | |
| Medtronic Vascular, INC. | $32.75 | 2019 | |
| Vifor Pharma, INC. | $31.55 | 2019-2021 | |
| Philips North America LLC | $30.50 | 2019-2025 | Extended Holter |
| Inogen, INC. | $23.94 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Cvrx, INC. | $22.19 | 2024 | Barostim Neo System |
| Bardy Diagnostics, INC. | $16.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Iqbal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.